Contineum Therapeutics, Inc.
CTNM
$12.16
-$0.06-0.49%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 28.39% | -14.73% | -19.74% | 61.75% | 63.56% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 208.42% | 104.55% | -18.72% | -21.06% | -35.29% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 29.81% | -14.04% | -19.74% | 60.50% | 61.61% |
|
|
|||||
| Total Current Assets | 29.81% | -14.04% | -19.74% | 60.50% | 61.61% |
| Net Property, Plant & Equipment | 31.18% | 536.71% | 468.12% | 398.05% | 362.13% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 8,433.33% | 8,766.67% | 6,100.00% | -99.85% | -99.77% |
| Total Assets | 29.97% | -11.66% | -17.38% | 60.45% | 63.24% |
|
|
|||||
| Total Accounts Payable | -43.90% | -43.74% | 172.62% | 539.47% | 185.20% |
| Total Accrued Expenses | -4.83% | 7.90% | 48.63% | -25.84% | 53.04% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 61.23% | 141.73% | 202.89% | 206.96% | 212.93% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -2.31% | 9.56% | 92.94% | 43.55% | 81.87% |
|
|
|||||
| Total Current Liabilities | -2.31% | 9.56% | 92.94% | 43.55% | 81.87% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 22.92% | -- | 3,691.15% | 3,996.40% | 4,350.93% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 5.90% | 78.73% | 198.49% | 105.32% | 159.22% |
|
|
|||||
| Common Stock & APIC | 38.91% | 9.58% | 3.38% | 3,879.85% | 4,342.21% |
| Retained Earnings | -51.09% | -57.75% | -61.43% | -59.63% | -56.24% |
| Treasury Stock & Other | 266.20% | -52.76% | 215.75% | 393.10% | -34.26% |
| Total Common Equity | 31.77% | -14.16% | -21.20% | 344.31% | 391.55% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 31.77% | -14.16% | -21.20% | 344.31% | 391.55% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 31.77% | -14.16% | -21.20% | 57.93% | 58.85% |
|
|
|||||